These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20842011)

  • 1. Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Netto EC; Brites C
    Clin J Pain; 2011 Feb; 27(2):131-5. PubMed ID: 20842011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
    Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.
    Castro NM; Rodrigues W; Freitas DM; Muniz A; Oliveira P; Carvalho EM
    Urology; 2007 May; 69(5):813-8. PubMed ID: 17482910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
    Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
    Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falls in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Facchinetti LD; Araújo AQ; Chequer GL; de Azevedo MF; de Oliveira RV; Lima MA
    Spinal Cord; 2013 Mar; 51(3):222-5. PubMed ID: 23165507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
    Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B
    J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.
    Rosadas C; Assone T; Yamashita M; Adonis A; Puccioni-Sohler M; Santos M; Paiva A; Casseb J; Oliveira ACP; Taylor GP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008761. PubMed ID: 33064742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Furukawa Y; Yamashita M; Usuku K; Izumo S; Nakagawa M; Osame M
    J Infect Dis; 2000 Nov; 182(5):1343-9. PubMed ID: 11010842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
    Deschamps R; Béra O; Belrose G; Lezin A; Bellance R; Signate A; Cabre P; Smadja D; Césaire R; Olindo S
    Int J Infect Dis; 2010 Nov; 14(11):e986-90. PubMed ID: 20851016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.
    Dixon PS; Bodner AJ; Okihiro M; Milbourne A; Diwan A; Nakamura JM
    West J Med; 1990 Mar; 152(3):261-7. PubMed ID: 2139754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.